PHusis Therapeutics Inc
Delivering Novel PH-Domain Inhibitors for Cancer
San Diego, United States · Founded 2025
- Headquarters
- San Diego, California
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- phusistherapeutics.com
About
PHusis Therapeutics is a precision oncology company designing novel PH-domain inhibitors using its proprietary computational modeling platform, PHuDock. The platform rapidly identifies inhibitors of proteins with regulatory PH-domains that drive cancer growth. PHusis has built a pipeline of drug leads targeting PDK1 for mutant NRAS melanoma, and CNKSR1 and PLEK for mutant KRAS in lung and colon cancer.
Summary
PHusis Therapeutics Inc is a Biotech company based in San Diego, United States, founded in 2025.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/phusis-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/phusis-therapeutics-inc" alt="PHusis Therapeutics Inc on Indexed.vc" width="260" height="76" /></a>